The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

Stocks rose on Wednesday, while oil prices declined to start the month, as hope grew that an end to the U.S.-Iran war was on ...

Trump's executive order says babies born in the U.S. are not entitled to citizenship if their parents are illegal immigrants ...

Steve Weiss, founder and managing partner at Short Hills Capital Partners, joins CNBC’s 'Halftime Report' to explain why he's ...

Steve Weiss, founder and managing partner at Short Hills Capital Partners, joins CNBC’s 'Halftime Report' to explain why he's more Meta and starting a new position in Micron.

The small-cap Russell 2000 ended March with losses of more than 5%, but the firm has spotted a few names that could see a surge.

Iran's Revolutionary Guard has warned a number of tech companies with Middle East operations that they'll be considered ...

Jeremy Siegel, professor of finance at the Wharton School and chief economist at Wisdomtree, joins 'Squawk on the Street' to ...

The president's comments are the latest threat to America's allies after their reluctance to help reopen the Strait of Hormuz ...

Generative AI is designed to please humans, but maybe not in the case of customer service chatbots dealing with angry ...

Daan Struyven, co-head of global commodities research at Goldman Sachs, joins 'Squawk Box' to discuss the state of energy ...

CNBC's MacKenzie Sigalos joins 'Squawk Box' to report on Apple's strategy in the AI race among big tech firms.